Pfizer buying Array Biopharma for $11.4B
AstraZeneca commits $630M to Korean drug R&D push
RWE and drug development
AstraZeneca’s Lokelma shows significant effect in ESRD trial
*please scroll down for all the latest news*
*scroll through previous pages at the bottom to get older news*
Want to stay updated on CP happenings? New features, new boards, CP wire articles, and more? Click here to subscribe
